Shanghai MicroPort Endovascular MedTech Co., Ltd.
SHH: 688016.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Qing Zhu
- Employees
- 826
- Headquarters
- Shanghai, China
- IPO year
- 2019
- Market cap
- CN¥12.3B
- Website
- https://www.endovastec.com
Loading 688016…
Loading profile data…Frequently asked questions about 688016
What does Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) do?
Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company w...
Where does 688016.SS trade?
Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) trades on the Shanghai Stock Exchange.
What sector is 688016.SS in?
Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Shanghai MicroPort Endovascular MedTech Co., Ltd.?
Qing Zhu is the chief executive officer of Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS).
Where is Shanghai MicroPort Endovascular MedTech Co., Ltd. headquartered?
Shanghai MicroPort Endovascular MedTech Co., Ltd. is headquartered in China.
Does 688016.SS pay a dividend?
Yes — Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) paid a trailing twelve-month dividend of CNY 1.65 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688016.SS go public?
Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) completed its initial public offering in 2019.